-
公开(公告)号：US20230192705A1
公开(公告)日：2023-06-22
申请号：US18009277
申请日：2021-06-10
Applicant: Betta Pharmaceuticals Co., Ltd
Inventor： Bang FU , Zhongxin SUN , Xiaofeng XU , Wei REN , Yinlong LI , Ling LI , Lieming DING , Jiabing WANG
IPC: C07D487/04 , C07D487/14 , C07D519/00 , C07F9/6561 , C07D491/107 , A61P35/00 , A61P11/00 , A61P35/02
CPC classification number: C07D487/04 , C07D487/14 , C07D519/00 , C07F9/6561 , C07D491/107 , A61P35/00 , A61P11/00 , A61P35/02
Abstract: Provided are compounds of Formula (I), methods of using the compounds as SHP2 inhibitors, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating SHP2-mediated diseases.
-
公开(公告)号：US20210395256A1
公开(公告)日：2021-12-23
申请号：US17311105
申请日：2019-12-06
Applicant: Betta Pharmaceuticals Co., Ltd.
Inventor： Bang FU , Yinlong LI , Wei REN , Jie CHEN , Xiangyong LIU , Jiabing WANG , Lieming DING
IPC: C07D487/04 , C07D519/00
Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as Trk inhibitors, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
-
公开(公告)号：US20240336594A1
公开(公告)日：2024-10-10
申请号：US18576708
申请日：2022-06-24
Applicant: BETTA PHARMACEUTICALS CO., LTD
Inventor： Bang FU , Yinlong LI , Wei REN , Qichao SHEN , Guolong DU , Xiaojun ZHOU , Yun SUN , Yuzhen ZHOU , Xiao SUN , Weidong CAI , Xiangyong LIU , Lieming DING , Jiabing WANG
IPC: C07D401/14 , A61K31/167 , A61K31/18 , A61K31/423 , A61K31/437 , A61K31/4375 , A61K31/44 , A61K31/443 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/497 , A61K31/501 , A61K31/5025 , A61K31/506 , A61K31/519 , A61K31/538 , C07C237/40 , C07C311/32 , C07C317/32 , C07C323/33 , C07D205/12 , C07D213/56 , C07D263/56 , C07D265/36 , C07D401/04 , C07D401/06 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/04 , C07D413/12 , C07D417/04 , C07D471/04 , C07D487/04 , C07D487/08 , C07D491/048 , C07D491/107
CPC classification number: C07D401/14 , A61K31/167 , A61K31/18 , A61K31/423 , A61K31/437 , A61K31/4375 , A61K31/44 , A61K31/443 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/497 , A61K31/501 , A61K31/5025 , A61K31/506 , A61K31/519 , A61K31/538 , C07C237/40 , C07C311/32 , C07C317/32 , C07C323/33 , C07D205/12 , C07D213/56 , C07D263/56 , C07D265/36 , C07D401/04 , C07D401/06 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/04 , C07D413/12 , C07D417/04 , C07D471/04 , C07D487/04 , C07D487/08 , C07D491/048 , C07D491/107
Abstract: A compound of formula I and a use thereof as an MALT1 inhibitor, and a pharmaceutical composition containing the compound. The compound can be used to treat diseases or disorders such as cancer.
-
Patent Agency Ranking
公开(公告)号：US20210269440A1
公开(公告)日：2021-09-02
申请号：US17260547
申请日：2019-07-19
Applicant: BETTA PHARMACEUTICALS CO., LTD
Inventor： Yao ZHANG , Yiqian WANG , Bang FU , Jie CHEN , Jiabing WANG , Lieming DING
IPC: C07D471/04
Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
-
公开(公告)号：US20210040118A1
公开(公告)日：2021-02-11
申请号：US17041455
申请日：2019-04-03
Applicant: BETTA PHARMACEUTICALS CO., LTD
Inventor： Yiqian WANG , Bang FU , Yao ZHANG , Xiangyong LIU , Jiabing WANG , Lieming DING
IPC: C07D513/04 , C07D417/14 , C07D495/04 , C07D471/04 , C07D277/56 , C07D487/04 , C07D271/10 , C07D519/00 , C07D498/04 , C07D285/12
Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
-
公开(公告)号：US20220119411A1
公开(公告)日：2022-04-21
申请号：US17259187
申请日：2019-07-12
Applicant: BETTA PHARMACEUTICALS CO., LTD
Inventor： Bang FU , Yao ZHANG , Yiqian WANG , Xiangyong LIU , Jiabing WANG , Lieming DING
IPC: C07D513/04 , C07D471/04 , C07D498/04 , C07D519/00 , C07D487/04 , C07D417/14
Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
-
公开(公告)号：US20220098183A1
公开(公告)日：2022-03-31
申请号：US17427112
申请日：2020-01-20
Applicant: Betta Pharmaceuticals Co.,Ltd
Inventor： Yiqian WANG , Yao ZHANG , Bang FU , Jiabing WANG , Lieming DING
IPC: C07D413/14 , C07D487/04 , C07D471/10 , C07D495/10 , C07D487/08 , C07D451/02 , C07D491/107 , C07D498/04
Abstract: Provided herein are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
-
公开(公告)号：US20210300909A1
公开(公告)日：2021-09-30
申请号：US17261013
申请日：2019-07-19
Applicant: BETTA PHARMACEUTICALS CO., LTD
Inventor： Yiqian WANG , Yao ZHANG , Bang FU , Jiabing WANG , Lieming DING
IPC: C07D413/06 , C07D263/57 , C07D401/04 , C07D401/06 , C07D413/14 , C07D417/06 , C07D277/66
Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
-
-
-
-
-
-
-
Search Results
8
records
(took 0.035 seconds)
